Symptoms of Post-traumatic Stress in Adult Drug-resistant Epilepsies
NCT ID: NCT04749901
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
129 participants
INTERVENTIONAL
2021-02-11
2023-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators propose a protocol using different types of measures: emotional, cognitive and physiological in order to answer our questions. In addition to patients with epilepsy, two groups of patients will be included: a group of patients with another chronic non-neurological disease to compare the prevalence of PTS symptoms and a group of patients with post-traumatic stress disorder ( PTSD) to compare with patients with epilepsy, cognitive and physiological measures.
Finally, the results of this study should allow to develop tools for assessing PTS symptoms in epilepsy and to develop specific management approaches
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies
NCT03244345
Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies
NCT03094793
Phenomenological Approach of Epilepsy in Patients With Epilepsy
NCT02952456
Collaborative Care in Posttraumatic Epilepsy
NCT05353452
Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy
NCT04782869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with epilepsy
Psycho-emotional and semiological measures
Surveys, interviews and measures
Patients with PTSD
Psycho-emotional and semiological measures
Surveys, interviews and measures
Patients with type 1 diabetes
Psycho-emotional and semiological measures
Surveys, interviews and measures
Patients with a heart rhythm disorder
Psycho-emotional and semiological measures
Surveys, interviews and measures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psycho-emotional and semiological measures
Surveys, interviews and measures
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Native French speaker;
* Level of education higher than the 3rd school level;
* Certain diagnosis of the pathology of the experimental group with which he will be associated, more precisely:
* Group of patients with epilepsy \[Group E\]: definite diagnosis of drug-resistant epilepsy (epileptic seizures persist despite the administration of daily treatment) established by a specialist physician.
* Group of patients with a heart rhythm disorder \[Group C\]: definite diagnosis of one of the following disorders: Atrial Fibrillation (AF); Syncope and Bouveret's disease established by a specialist.
* Group of patients with T1 diabetes mellitus \[Group D\]: definite diagnosis of type 1 diabetes established by a specialist doctor.
* Group of patients with PTSD \[Group T\]: definite diagnosis of PTSD established by a specialist doctor.
* Person having given his non-objection
Exclusion Criteria
* Breastfeeding women;
* Severe cognitive impairment
* Addiction to alcohol or drugs (including drugs other than those related to epilepsy or the chronic disease from which the patient has);
* Other neurological and / or psychiatric disorders than CNEP or epilepsy except anxiety and depressive disorders;
* Adults under guardianship or under judicial protection
* People deprived of their liberty
* Inability to read French.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Olivier ARNAUD
Role: STUDY_DIRECTOR
Assistance Publique Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hopitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB
Identifier Type: OTHER
Identifier Source: secondary_id
2020-42
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.